Comment le bénéfice par action récent de LNTH se compare-t-il aux attentes ?
Comment les revenus de Lantheus Holdings Inc LNTH se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour Lantheus Holdings Inc ?
Quel est le score de qualité des bénéfices pour Lantheus Holdings Inc ?
Quand Lantheus Holdings Inc publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de Lantheus Holdings Inc ?
Lantheus Holdings Inc a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
$67.28
Prix d'ouverture
$67.68
Plage de la journée
$65.84 - $68.84
Plage de 52 semaines
$47.25 - $111.29
Volume
1.0M
Volume moyen
961.2K
BPA (TTM)
2.38
Rendement en dividend
--
Capitalisation boursière
$4.5B
Qu’est-ce que LNTH ?
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The company is headquartered in North Billerica, Massachusetts and currently employs 808 full-time employees. The company went IPO on 2015-06-25. The firm's product categories include Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Others. The firm's Radiopharmaceutical Oncology products help healthcare professionals (HCPs) find, fight and follow cancer. The firm's Precision Diagnostic products assist HCPs to find and follow diseases. Its Strategic Partnerships include biomarkers and digital solutions in support of its partners’ therapeutic development, out-licensing agreements for non-core assets and optimization of its assets geographically. The firm's commercial products are used by cardiologists, internal medicine physicians, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists working in a variety of clinical settings.